ESC Premium Access

The effect of PCI complexity on the efficacy and safety of dabigatran dual therapy vs warfarin triple therapy in atrial fibrillation: a subgroup analysis from the RE-DUAL PCI trial

Topic: Thrombosis, Platelets, and Coagulation

Congress Presentation

About the speaker

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)
38 presentations
0 follower

6 more presentations in this session

Long vs. short dual antiplatelet therapy in ACS patients treated with prasugrel or ticagrelor and coronary revascularization: a propensity score analysis from the RENAMI registry

Speaker: Doctor F. Fioravanti (Milan, IT)


Exploring the value of the PRECISE-DAPT score after complex percutaneous coronary intervention to inform dual antiplatelet therapy duration decision-making.

Speaker: Doctor F. Costa (Messina, IT)


Diagnostic evaluation of a new high-sensitive point-of-care troponin I assay

Speaker: Doctor N. Soerensen (Hamburg, DE)


Diagnostic accuracy of high sensitive cardiac troponin T in patients with suspected acute coronary syndrome and severe chronic kidney disease

Speaker: Doctor B. Alushi (Munich, DE)


Does complying guidelines matter?

Speaker: Doctor I. Campos (Braga, PT)


Access the full session

ACS diagnosis and treatment

Speakers: Professor C. Cannon, Doctor F. Fioravanti, Doctor F. Costa, Doctor N. Soerensen, Doctor B. Alushi...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb